A Device to Treat Bradykinesia in Parkinson's Disease

Information

  • Research Project
  • 6444375
  • ApplicationId
    6444375
  • Core Project Number
    R43NS043000
  • Full Project Number
    1R43NS043000-01
  • Serial Number
    43000
  • FOA Number
  • Sub Project Id
  • Project Start Date
    9/20/2002 - 22 years ago
  • Project End Date
    7/31/2003 - 21 years ago
  • Program Officer Name
    SHEEHY, PAUL A.
  • Budget Start Date
    9/20/2002 - 22 years ago
  • Budget End Date
    7/31/2003 - 21 years ago
  • Fiscal Year
    2002
  • Support Year
    1
  • Suffix
  • Award Notice Date
    9/30/2002 - 22 years ago
Organizations

A Device to Treat Bradykinesia in Parkinson's Disease

DESCRIPTION (provided by applicant): This proposal evaluates a prototype Transcutaneous Electrical Movement Timing Stimulator (TEMTS) with the potential to improve akinesia/ bradykinesia in Parkinson?s Disease (PD). We will evaluate improvements through a randomized sham versus actual 20 patient clinical study with each human subject as its own control, utilizing a battery of quantitative motor performance tests and instrumentation. TEMTS could significantly enhance everyday task performance, such as, walking, cooking, eating, personal hygiene and exercise, improving the quality of life for the 1.2 million people in the U.S. affected by PD. PD is characterized by movement dysfunction resulting from selective neurodegeneration of dopamine producing neurons of the substantia nigra pars compacta (SNpc). Promisingly, the dysfunction appears to be pharmacologic resulting in reversible physiologic abnormalities. The common scenario of ?paradoxical kinesia?, where PD patients can move normally with correct external sensory cueing, is empirical evidence of even advanced PD patients exhibiting ability to produce normal movements. We have produced and demonstrated in a case study, a sensory cueing device that normalizes many of these PD motor deficits. This proposal evaluates TEMTS performance in a statistically significant patient population and evolves the design to improve efficacy leading to an alternative treatment for PD motor dysfunction.

IC Name
NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE
  • Activity
    R43
  • Administering IC
    NS
  • Application Type
    1
  • Direct Cost Amount
  • Indirect Cost Amount
  • Total Cost
    100000
  • Sub Project Total Cost
  • ARRA Funded
  • CFDA Code
    853
  • Ed Inst. Type
  • Funding ICs
    NINDS:100000\
  • Funding Mechanism
  • Study Section
    ZRG1
  • Study Section Name
    Special Emphasis Panel
  • Organization Name
    SENTEL CORPORATION
  • Organization Department
  • Organization DUNS
  • Organization City
    ALEXANDRIA
  • Organization State
    VA
  • Organization Country
    UNITED STATES
  • Organization Zip Code
    22314
  • Organization District
    UNITED STATES